Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,521 | 487 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,047 | 43 | $0 (2024) |
| Novo Nordisk Inc | $991.47 | 91 | $0 (2024) |
| ABBVIE INC. | $904.17 | 55 | $0 (2024) |
| Lilly USA, LLC | $580.77 | 35 | $0 (2024) |
| PFIZER INC. | $431.89 | 55 | $0 (2024) |
| Corcept Therapeutics | $428.07 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $418.78 | 25 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $317.99 | 23 | $0 (2024) |
| Amgen Inc. | $268.74 | 16 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $240.47 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,115 | 55 | AstraZeneca Pharmaceuticals LP ($258.20) |
| 2023 | $1,563 | 89 | ABBVIE INC. ($444.55) |
| 2022 | $970.15 | 48 | Novo Nordisk Inc ($249.44) |
| 2021 | $94.65 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($42.46) |
| 2020 | $290.61 | 20 | PFIZER INC. ($113.92) |
| 2019 | $735.48 | 60 | PFIZER INC. ($137.06) |
| 2018 | $1,237 | 74 | Novartis Pharmaceuticals Corporation ($190.69) |
| 2017 | $1,520 | 135 | Lilly USA, LLC ($244.05) |
All Payment Transactions
488 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $100.75 | General |
| Category: Diabetes Care | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.74 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.52 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.14 | General |
| Category: Obesity | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.65 | General |
| Category: Cardiovascular | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.24 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Cardio-renal | ||||||
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Cardio-renal | ||||||
| 06/25/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/20/2024 | Galderma Laboratories, L.P. | DYSPORT (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| 06/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 511 | 958 | $92,981 | $49,428 |
| 2022 | 11 | 513 | 766 | $71,998 | $43,602 |
| 2021 | 7 | 275 | 598 | $53,582 | $26,619 |
| 2020 | 8 | 378 | 541 | $54,182 | $31,846 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 374 | $62,201 | $29,936 | 48.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 78 | 78 | $13,962 | $9,557 | 68.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 66 | $7,371 | $3,997 | 54.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 63 | 63 | $2,505 | $2,104 | 84.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 63 | $1,890 | $1,850 | 97.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 14 | $1,269 | $694.02 | 54.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 56 | 80 | $2,000 | $667.08 | 33.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 29 | $548.39 | $293.23 | 53.5% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2023 | 14 | 14 | $280.00 | $133.28 | 47.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 155 | $775.00 | $121.58 | 15.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 22 | $180.00 | $75.02 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 90 | 196 | $30,576 | $18,199 | 59.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 77 | 77 | $13,783 | $9,645 | 70.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 100 | 100 | $15,700 | $7,830 | 49.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 53 | $5,565 | $3,639 | 65.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 62 | 62 | $2,170 | $1,961 | 90.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 62 | 62 | $1,860 | $1,733 | 93.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 15 | $283.65 | $163.19 | 57.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 35 | 44 | $1,100 | $129.87 | 11.8% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 11 | 12 | $235.00 | $114.24 | 48.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 14 | 123 | $615.00 | $111.49 | 18.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 22 | $110.00 | $75.46 | 68.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 163 | 323 | $46,890 | $23,513 | 50.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 38 | $3,730 | $2,309 | 61.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 26 | 28 | $560.00 | $263.52 | 47.1% |
About Shelli Ridge
Shelli Ridge is a Family Medicine healthcare provider based in West Chester, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2011. The National Provider Identifier (NPI) number assigned to this provider is 1356629356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shelli Ridge has received a total of $7,526 in payments from pharmaceutical and medical device companies, with $1,115 received in 2024. These payments were reported across 488 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,521).
As a Medicare-enrolled provider, Ridge has provided services to 1,677 Medicare beneficiaries, totaling 2,863 services with total Medicare billing of $151,495. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location West Chester, OH
- Active Since 07/26/2011
- Last Updated 02/06/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1356629356
Products in Payments
- FARXIGA (Drug) $679.21
- Korlym (Drug) $428.07
- VRAYLAR (Drug) $415.21
- Ozempic (Drug) $379.33
- UBRELVY (Drug) $335.35
- MOUNJARO (Drug) $275.08
- BREZTRI (Drug) $238.34
- ENTRESTO (Drug) $225.83
- TRULICITY (Drug) $222.26
- JARDIANCE (Drug) $211.68
- V-GO (Device) $197.96
- Livalo (Drug) $197.03
- Rybelsus (Drug) $182.24
- QULIPTA (Drug) $169.08
- Victoza (Drug) $140.03
- CHANTIX (Drug) $138.70
- AREXVY (Drug) $124.52
- Kerendia (Drug) $124.00
- Prolia (Biological) $110.75
- Aimovig (Biological) $103.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in West Chester
Ronald Reynolds, Md, MD
Family Medicine — Payments: $23,284
John Hornick, M.d, M.D
Family Medicine — Payments: $8,653
Colin Turney, Md, MD
Family Medicine — Payments: $8,258
Charles Catania, M.d, M.D
Family Medicine — Payments: $8,063
Omar Siddiqi, M.d, M.D
Family Medicine — Payments: $7,577
Dr. Susan Dallas-Feeney, D.o, D.O
Family Medicine — Payments: $6,348